Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$321,891,596
+$53,327,115 QoQ
Shares Held
1,279,175
+3.6% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#117
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$2,013,120
PutShares
8,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $5,124,714,999 across 15 Drug Manufacturers - General names. ABBV ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,697,061 | $2,035,506,044 | |
| 2 | JNJ |
Johnson & Johnson
|
4,126,113 | $1,047,908,917 | |
| 3 | AZN |
Astrazeneca PLC
|
2,746,590 | $520,808,395 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,533,955 | $454,113,217 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
1,279,175 | $321,891,596 | |
| 6 | PFE |
Pfizer Inc
|
10,281,652 | $247,582,179 | |
| 7 | AMGN |
Amgen Inc
|
646,798 | $234,218,491 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,361,825 | $172,052,970 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,013,120 | 8,000 | Put | Defined | 2026-08-13 | |
| 2026-06-30 | $321,891,596 | 1,279,175 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $268,564,481 | 1,234,836 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $270,279,906 | 1,182,896 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $275,059,331 | 1,187,956 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $230,215,947 | 1,240,254 | Shares | Defined | 2025-08-25 | |
| 2025-03-31 | $287,683,111 | 1,373,058 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $263,751,934 | 1,484,254 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $438,845,387 | 2,222,227 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $335,042,879 | 1,953,375 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $337,591,183 | 1,853,878 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $245,154,945 | 1,581,951 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $233,749,929 | 1,568,160 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $215,020,726 | 1,595,938 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $281,373,631 | 1,765,537 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $254,254,063 | 1,573,257 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $138,850,981 | 1,034,580 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $182,353,214 | 1,190,606 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $184,103,625 | 1,135,671 | Shares | Defined | 2022-05-23 | |
| 2021-12-31 | $151,897,135 | 1,121,840 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $104,949,527 | 972,926 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $169,591,572 | 1,505,607 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $114,266,251 | 1,055,870 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $68,039,713 | 634,995 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $75,351,661 | 860,277 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $90,706,734 | 923,882 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $41,265,799 | 541,617 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||